Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription Articles published in Oncogene Retrieve available abstracts of 21 articles: HTML format

Single Articles

June 2025
1. LIU J, Xu J, Sun R, Wang X, et al
   MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia progression via inducing MYCT1 degradation.
   Oncogene. 2025 Jun 18. doi: 10.1038/s41388-025-03464.
   PubMed     Abstract available
   
   
   
2. LI YQ, Liu D, Wang LL, Shao YL, et al
   WTAP-mediated m(6)A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML.
   Oncogene. 2025;44:1504-1516.
   PubMed     Abstract available
   
   
   
3. XIE Y, Zhao R, Zheng Y, Li Y, et al
   Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import.
   Oncogene. 2025;44:1646-1661.
   PubMed     Abstract available
   
   
   May 2025
4. YAO L, Zhang X, Li X, Xu J, et al
   circAFF2 promotes the development of AML by binding to PML mRNA.
   Oncogene. 2025;44:1234-1244.
   PubMed     Abstract available
   
   
   March 2025
5. ZHANG L, Wang X, Hu D, Li S, et al
   SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression.
   Oncogene. 2025 Mar 27. doi: 10.1038/s41388-025-03350.
   PubMed     Abstract available
   
   
   February 2025
6. TIAN X, Zhang L, Xiang G, Tang Y, et al
   Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation.
   Oncogene. 2025 Feb 22. doi: 10.1038/s41388-025-03309.
   PubMed     Abstract available
   
   
   
7. VALIMA E, Varis V, Bureiko K, Lempiainen JK, et al
   SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells.
   Oncogene. 2025 Feb 14. doi: 10.1038/s41388-025-03305.
   PubMed     Abstract available
   
   
   
8. ZHANG J, Zhai J, Wong CC, Chen H, et al
   Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
   Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
   PubMed    
   
   
   November 2024
9. DUAN C, Lin X, Zou W, He Q, et al
   Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation.
   Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03215.
   PubMed     Abstract available
   
   
   
10. ZHANG C, Hao T, Bortoluzzi A, Chen MH, et al
    Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential.
    Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197.
    PubMed     Abstract available
    
    
    August 2024
11. SERGIO I, Varricchio C, Patel SK, Del Gaizo M, et al
    Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL.
    Oncogene. 2024;43:2535-2547.
    PubMed     Abstract available
    
    
    June 2024
12. WANG G, Zhang W, Ren J, Zeng Y, et al
    The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
    Oncogene. 2024;43:1900-1916.
    PubMed     Abstract available
    
    
    April 2024
13. SAFFERTHAL C, Rohde K, Fulda S
    Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022.
    PubMed    
    
    
    March 2024
14. GUO T, Wang Y, Sun X, Hou S, et al
    Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1.
    Oncogene. 2024 Mar 21. doi: 10.1038/s41388-024-03006.
    PubMed     Abstract available
    
    
    December 2023
15. LEI H, Xu H, Yang L, Wang Y, et al
    USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia.
    Oncogene. 2023 Dec 16. doi: 10.1038/s41388-023-02921.
    PubMed    
    
    
    
16. NOURA M, Matsuo H, Yasuda T, Tsuzuki S, et al
    Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02913.
    PubMed     Abstract available
    
    
    
17. DI MAMBRO A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al
    SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
    Oncogene. 2023;42:3670-3683.
    PubMed     Abstract available
    
    
    November 2023
18. ERKNER E, Hentrich T, Schairer R, Fitzel R, et al
    The ROR?/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
    Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02903.
    PubMed     Abstract available
    
    
    October 2023
19. XIE X, Zhang W, Zhou X, Xu B, et al
    Low doses of IFN-gamma maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
    Oncogene. 2023 Oct 23. doi: 10.1038/s41388-023-02874.
    PubMed     Abstract available
    
    
    September 2023
20. MA H, Cui J, Liu Z, Fang W, et al
    Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia.
    Oncogene. 2023 Sep 26. doi: 10.1038/s41388-023-02848.
    PubMed     Abstract available
    
    
    
21. PAWLIKOWSKA P, Delestre L, Gregoricchio S, Oppezzo A, et al
    FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
    Oncogene. 2023;42:2764-2775.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.